Another cohort study comprising 131 patients with ovarian cancer and 100 age-matched healthy controls demonstrated that preoperative collected serum Nectin-4 levels were significantly higher in patients with ovarian cancer than in controls [11]. This evidence concerns the gene NECTIN4 and ovarian cancer.